News about Global Pharma

Modicus Prime Secures USD 3.5 Million in Series Seed Funding

Modicus Prime has received USD 3.5 million in series seed funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms.

Global Pharma | 16/07/2024 | By Aishwarya |  648

AusperBio Receives USD 37 Million in Series A Financing Round

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A financing round.

Global Pharma | 16/07/2024 | By Aishwarya |  652

Alembic Pharma Gets USFDA Tentative Approval for Selexipag for Injection

Alembic Pharmaceuticals has secured tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Selexipag for Injection, 1,800 mcg/vial.

Global Pharma | 15/07/2024 | By Aishwarya |  956

Moderna and Mitsubishi Tanabe Pharma to Promote mRNA Respiratory Vaccine in Japan

Moderna, Inc. has signed a joint agreement with Mitsubishi Tanabe Pharma regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax.

Global Pharma | 15/07/2024 | By Aishwarya |  629

BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza

Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS).

Global Pharma | 12/07/2024 | By Aishwarya |  614

AusperBio Gets BTD for AHB-137 in Chronic Hepatitis B Treatment

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. have announced that their investigational drug AHB-137 has received Breakthrough Therapy Designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China.

Global Pharma | 11/07/2024 | By Aishwarya |  1014

Promoters of Sudeep Pharma Completes Acquisition from JRS Pharma

Sudeep Pharma Pvt. Ltd.’s promoters have completed the acquisition of shares from their joint venture partners – JRS PHARMA, regaining 100 percent ownership of the company.

Global Pharma | 11/07/2024 | By Aishwarya |  618

Sanofi Starts Shipping US Influenza Vaccines for 2024-25

Sanofi has begun shipped its first influenza (flu) vaccines across the U.S. in preparation for the 2024–25 flu season.

Global Pharma | 11/07/2024 | By Aishwarya |  1441

Pint Pharma Announces Approval of ORLADEYO in Peru

Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older.

Global Pharma | 10/07/2024 | By Aishwarya |  747

Life Molecular Imaging Expands Partnership with Jubilant Radiopharma to Distribute Neurace

Life Molecular Imaging (LMI) has expanded their strategic partnership and licensing agreement with Jubilant Radiopharma to provide and distribute Neuraceq from Jubilant's single photon emission computed tomography (SPECT) and Positron Emision Tomography (PET) radiopharmaceutical manufacturing site located in Mobile, AL.

Global Pharma | 10/07/2024 | By Aishwarya |  933